Please contact us for more information or to learn if you are eligible to participate.
This phase II/III trial studies how well circulating tumor deoxyribonucleic acid (ctDNA) testing in the blood works in predicting treatment for patients with stage IIA colon cancer after surgery.
Dr. Jose Cruz
Edgar Lopez Pacheco
National Cancer Institute (NCI)
Type of Trial